India Still Viable for Drug Innovation, Hisey Says
April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Most Recent Videos
Soylent: The Food of the Future?
25:51 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)